The Complex Role of the miR-17-92 Cluster in Stroke: Mechanistic Insights and Biomarker Potential

Cornelia Braicu1, Mihaela Molnar2, Ekaterina Isachesku1

  • 1Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.

Genes
|June 26, 2025
PubMed

Insights

MicroRNAs, specifically the miR-17-92 cluster, play a crucial role in stroke pathology and recovery. Understanding these microRNAs offers potential for novel diagnostic and therapeutic strategies for ischemic stroke.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Stroke is a major global health concern, with ischemic stroke (IS) being the most common type.
  • MicroRNAs (miRNAs) are increasingly recognized for their significant roles in the complex pathogenesis of stroke.
  • The miR-17-92 cluster and its related microRNAs are key regulators influencing stroke development and post-stroke recovery.

Purpose of the Study:

  • To review the regulatory functions of the miR-17-92 cluster in stroke pathology.
  • To highlight the involvement of specific miRNAs (e.g., miR-19a, miR-18a, miR-92a) in neurogenesis, apoptosis, and axonal growth.
  • To explore the therapeutic potential of targeting these miRNAs for improved stroke treatment and recovery.

Main Methods:

  • Literature review and synthesis of preclinical findings on miRNA function in stroke models.
  • Analysis of the role of miR-17-92 cluster members in key pathological processes like inflammation, apoptosis, neuroprotection, and tissue repair.
  • Identification of specific miRNA targets and pathways relevant to stroke injury and regeneration.

Main Results:

  • The miR-17-92 cluster and its paralogs regulate critical pathways in stroke, including inflammation, apoptosis, neuroprotection, and tissue repair.
  • Specific miRNAs within the cluster, such as miR-19a, miR-18a, and miR-92a, are implicated in neurogenesis, axonal elongation, and reducing neuronal apoptosis.
  • Preclinical evidence suggests that modulating the miR-17-92 cluster can enhance neural regeneration and functional recovery post-stroke.

Conclusions:

  • The miR-17-92 cluster represents a significant regulatory network in stroke pathogenesis and recovery.
  • Targeting specific miRNAs within this cluster holds promise for developing novel therapeutic interventions for ischemic stroke.
  • Further research into the precise mechanisms of miR-17-92 members is essential for advancing stroke treatment strategies.